Hong Kong Stock Announcement Nuggets | CICC plans to exchange shares to absorb and merge Dongxing Securities and Cinda Securities

[Important matters]

CICC (03908) plans to exchange shares to absorb and merge Dongxing Securities (601198.SH) and Cinda Securities (601059.SH) to resume trading on December 18

Yuanda Pharmaceutical (00512): Self-developed, globally innovative radionuclide conjugation drug GPN01530 approved for clinical research in the US

Changfeng Pharmaceutical (02652): Clinical trial application for olotadine mometasone nasal spray accepted by NMPA

CRRC (01766) and its subsidiaries have signed a total of about 53.31 billion yuan of major contracts in the past three months

Guangzhou Pharmaceutical, a subsidiary of Baiyunshan (00874), plans to spend about 500 million yuan to acquire 100% of Zhejiang Pharmaceutical Industry Co., Ltd.

[Repurchase]

China Metallurgical (01618) plans to repurchase no more than 2 billion yuan of A shares and 500 million yuan of H shares

Tencent Holdings (00700) spent HK$636 million to buy back 1.557 million shares on December 17

Chuangke Industrial (00669) spent HK$44.91 million to buy back 500,000 shares on December 17

Country Garden Services (06098) spent HK$23.174,800 to buy back 3.697 million shares on December 17

COSCO Marine Holdings (01919) spent HK$386.13 million to repurchase 2,857,500 shares on December 17